<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-abiraterone.xml</id>
  <title>Recalls Watch: Abiraterone</title>
  <link rel="self" href="https://recalls.watch/feed/substance-abiraterone.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-11-04T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/100128/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Abiraterone Acetate Tablets USP 500 mg</title>
    <link href="https://recalls.watch/recall/fda/100128/"/>
    <updated>2026-11-04T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Not Elsewhere Classified</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/100046/</id>
    <title>Hikma Pharmaceuticals USA INC.: Abirtega</title>
    <link href="https://recalls.watch/recall/fda/100046/"/>
    <updated>2026-10-28T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.</summary>
  </entry>
</feed>
